World News: 22:39 GMT Monday 16th April 2018. [AstraZeneca via Thomson Reuters ONE via SPi World News]
Phase Ib Study 006 long-term follow-up shows clinical activity in PD-L1 greater than or equal to 25 and less than 25 groups in 2nd-line non-small cell lung cancer Phase I Study 10 data shows clinical activity with combination treatment in 2 nd-line...
Thomson Reuters: 22:39 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.